Leukemia Clinical Trials

Showing 5201-5220 of 8,366 trials

Study on OsseoSpeed™ TX Implants in the Upper Jaw in a Chinese Population

NCT01389245

The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior maxilla up to 3 years after loading. Hypothesis: Early loading of the posterior maxilla is a safe and predictable procedure.

Partially Edentulous Jaw

Dentsply Sirona Implants and Consumables42 participantsStarted Jun 2011

Beijing, China • Guangzhou, China • Nanjing, China

COMPLETEDPhase 2

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

NCT01490723

The goal of this clinical research study is to learn if adding Zevalin (ibritumomab tiuxetan) to low-intensity chemotherapy (the combination of rituximab, bendamustine, and fludarabine), followed by an allogeneic stem cell transplant, can help to control lymphoma. The safety of this combination will also be studied. Two (2) forms of ibritumomab tiuxetan will be used in this study. 90Y-ibritumomab tiuxetan is designed to attach to lymphoma cells and destroy the cells using a radioactive particle that is attached to it. 111In-ibritumomab tiuxetan is like 90Y- ibritumomab tiuxetan, but the radioactive particle that is attached to it does not kill lymphoma cells. The radioactive particle makes the drug able to be seen inside your body. It is being used in this study to predict how fast the study drug will travel in the body and how long the drug stays in the body. Rituximab is designed to attach to lymphoma cells, which may cause them to die. Bendamustine is designed to damage and destroy the DNA (genetic material) of cancer cells. Fludarabine is designed to make cancer cells less able to repair damaged DNA. This may increase the likelihood of the cells dying.

LeukemiaLymphoma

M.D. Anderson Cancer Center20 participantsStarted Jan 2013

Houston, Texas, United States

Study on OsseoSpeed™ TX Implants in the Upper Jaw in a Chinese Population

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Related Searches

Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer

Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer

Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck

"Effect of Sonic Activation Assisted Irrigation and Apical Enlargement on Postoperative Endodontic Pain"

Fourth International Study of Mechanical Ventilation From VENTILA GROUP

MicroRNA-126 and Its Target VCAM-1Dermatitis to Nickel

Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach

An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC

INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)

CD38-targeted Chimeric Antigen Receptor T Cell (CART) in Relapesd or Refractory Acute Myeloid Leukemia

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2

Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC